S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
Sinema took Wall Street money while killing tax on investors
“No Historic Crash Is Coming, What’s NEXT, Is Much Worse…” (PhD Economist) (Ad)
Expanded IRS free-file system one step closer in Dems' bill
Climate bill: Could coal communities shift to nuclear?
Germans urged to cap heat in offices this winter to save gas
Trading Millionaire Reveals, “2008 Was My Most Profitable Year” (Ad)
Italy's Lake Garda shrinks to near-historic low amid drought
The 7 Types Of People Every Entrepreneur Needs In Their Inner Circle -- And How To Find Them
Former Deutsche Bank Co-CEO Anshu Jain dies
Sell every Stock except ONE (Ad)
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
Sinema took Wall Street money while killing tax on investors
“No Historic Crash Is Coming, What’s NEXT, Is Much Worse…” (PhD Economist) (Ad)
Expanded IRS free-file system one step closer in Dems' bill
Climate bill: Could coal communities shift to nuclear?
Germans urged to cap heat in offices this winter to save gas
Trading Millionaire Reveals, “2008 Was My Most Profitable Year” (Ad)
Italy's Lake Garda shrinks to near-historic low amid drought
The 7 Types Of People Every Entrepreneur Needs In Their Inner Circle -- And How To Find Them
Former Deutsche Bank Co-CEO Anshu Jain dies
Sell every Stock except ONE (Ad)
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
Sinema took Wall Street money while killing tax on investors
“No Historic Crash Is Coming, What’s NEXT, Is Much Worse…” (PhD Economist) (Ad)
Expanded IRS free-file system one step closer in Dems' bill
Climate bill: Could coal communities shift to nuclear?
Germans urged to cap heat in offices this winter to save gas
Trading Millionaire Reveals, “2008 Was My Most Profitable Year” (Ad)
Italy's Lake Garda shrinks to near-historic low amid drought
The 7 Types Of People Every Entrepreneur Needs In Their Inner Circle -- And How To Find Them
Former Deutsche Bank Co-CEO Anshu Jain dies
Sell every Stock except ONE (Ad)
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
Sinema took Wall Street money while killing tax on investors
“No Historic Crash Is Coming, What’s NEXT, Is Much Worse…” (PhD Economist) (Ad)
Expanded IRS free-file system one step closer in Dems' bill
Climate bill: Could coal communities shift to nuclear?
Germans urged to cap heat in offices this winter to save gas
Trading Millionaire Reveals, “2008 Was My Most Profitable Year” (Ad)
Italy's Lake Garda shrinks to near-historic low amid drought
The 7 Types Of People Every Entrepreneur Needs In Their Inner Circle -- And How To Find Them
Former Deutsche Bank Co-CEO Anshu Jain dies
Sell every Stock except ONE (Ad)
NYSE:WAT

Waters - WAT Stock Forecast, Price & News

$335.23
+3.61 (+1.09%)
(As of 08/12/2022 12:00 AM ET)
Add
Compare
Today's Range
$330.56
$336.16
50-Day Range
$308.51
$365.55
52-Week Range
$288.32
$428.22
Volume
204,789 shs
Average Volume
359,114 shs
Market Capitalization
$20.07 billion
P/E Ratio
29.25
Dividend Yield
N/A
Price Target
$353.00

Waters MarketRank™ Forecast

Analyst Rating
Hold
2.20 Rating Score
Upside/​Downside
5.3% Upside
$353.00 Price Target
Short Interest
Healthy
2.07% of Float Sold Short
Dividend Strength
N/A
Sustainability
-1.15
Upright™ Environmental Score
News Sentiment
-0.06mentions of Waters in the last 14 days
Based on 46 Articles This Week
Insider Trading
Selling Shares
$1.32 M Sold Last Quarter
Proj. Earnings Growth
8.58%
From $12.00 to $13.03 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.96 out of 5 stars

Computer And Technology Sector

489th out of 665 stocks

Analytical Instruments Industry

20th out of 31 stocks

WAT stock logo

About Waters (NYSE:WAT) Stock

Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. Its MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. The company offers thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by life science, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. Waters Corporation was founded in 1958 and is headquartered in Milford, Massachusetts.

Wall Street Analysts Forecast Growth

A number of research analysts recently issued reports on the stock. UBS Group boosted their target price on shares of Waters from $349.00 to $375.00 and gave the company a "neutral" rating in a research report on Thursday, August 4th. Cowen upped their price objective on shares of Waters to $378.00 in a report on Tuesday. Bank of America upgraded shares of Waters from an "underperform" rating to a "neutral" rating and increased their target price for the company from $320.00 to $330.00 in a report on Tuesday, May 17th. Wells Fargo & Company upgraded shares of Waters from an "underweight" rating to an "equal weight" rating and lowered their target price for the company from $320.00 to $315.00 in a report on Monday, April 25th. Finally, Robert W. Baird increased their target price on shares of Waters from $340.00 to $348.00 in a report on Wednesday, August 3rd. Four investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of "Hold" and an average target price of $353.00.

Waters Stock Up 1.1 %

Shares of NYSE:WAT opened at $335.23 on Friday. The company has a market cap of $20.07 billion, a price-to-earnings ratio of 29.25, a PEG ratio of 3.60 and a beta of 0.81. The firm's fifty day moving average is $334.86 and its 200 day moving average is $323.71. Waters has a 52 week low of $288.32 and a 52 week high of $428.22. The company has a quick ratio of 1.55, a current ratio of 2.10 and a debt-to-equity ratio of 3.66.

Waters (NYSE:WAT - Get Rating) last posted its quarterly earnings results on Tuesday, August 2nd. The medical instruments supplier reported $2.75 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.63 by $0.12. Waters had a return on equity of 203.31% and a net margin of 24.21%. The firm had revenue of $714.30 million during the quarter, compared to analyst estimates of $706.77 million. During the same quarter in the previous year, the firm earned $2.60 EPS. Waters's quarterly revenue was up 4.8% compared to the same quarter last year. On average, equities research analysts expect that Waters will post 12 earnings per share for the current year.

Insider Activity at Waters

In other Waters news, Director Christopher A. Kuebler sold 4,000 shares of the company's stock in a transaction that occurred on Thursday, May 19th. The stock was sold at an average price of $328.78, for a total value of $1,315,120.00. Following the completion of the transaction, the director now directly owns 14,064 shares in the company, valued at approximately $4,623,961.92. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. 0.77% of the stock is currently owned by corporate insiders.

Receive WAT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Waters and its competitors with MarketBeat's FREE daily newsletter.

WAT Stock News Headlines

Cowen Increases Waters (NYSE:WAT) Price Target to $378.00
See More Headlines
Receive WAT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Waters and its competitors with MarketBeat's FREE daily newsletter.

WAT Company Calendar

Last Earnings
8/02/2022
Today
8/13/2022
Next Earnings (Estimated)
11/01/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Analytical instruments
Sub-Industry
Life Sciences Tools & Services
CUSIP
94184810
Employees
7,800
Year Founded
1958

Price Target and Rating

Average Stock Price Forecast
$353.00
High Stock Price Forecast
$378.00
Low Stock Price Forecast
$315.00
Forecasted Upside/Downside
+5.3%
Consensus Rating
Hold
Rating Score (0-4)
2.20
Research Coverage
5 Analysts

Profitability

Net Income
$692.84 million
Pretax Margin
28.06%

Debt

Sales & Book Value

Annual Sales
$2.79 billion
Cash Flow
$13.68 per share
Book Value
$6.55 per share

Miscellaneous

Free Float
59,415,000
Market Cap
$20.07 billion
Optionable
Optionable
Beta
0.81

Social Links


Key Executives

  • Dr. Udit Batra Ph.D. (Age 51)
    Pres, CEO & Director
    Comp: $3.37M
  • Mr. Amol Chaubal (Age 45)
    Sr. VP & CFO
    Comp: $987.45k
  • Dr. Belinda Gaye Hyde Ph.D. (Age 51)
    Sr. VP & Chief HR Officer
    Comp: $1.31M
  • Mr. Jonathan M. Pratt (Age 52)
    Sr. VP of Waters Division
    Comp: $1.31M
  • Ms. Jianqing Y. Bennett (Age 52)
    Sr. VP of TA Instruments Division
    Comp: $1.11M
  • Mr. Daniel J. Welch
    Sr. VP of Global Operations
  • Caspar Tudor
    Manage of Investor Relation
  • Ms. Keeley A. Aleman (Age 45)
    Sr. VP, Gen. Counsel & Corp. Sec.
  • Kevin Kempskie
    Sr. Director of PR
  • Ms. Kristen Garvey
    VP of Corp. Communications













WAT Stock - Frequently Asked Questions

Should I buy or sell Waters stock right now?

5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Waters in the last twelve months. There are currently 4 hold ratings and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" WAT shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in WAT, but not buy additional shares or sell existing shares.
View WAT analyst ratings
or view top-rated stocks.

What is Waters' stock price forecast for 2022?

5 analysts have issued 1-year price objectives for Waters' shares. Their WAT share price forecasts range from $315.00 to $378.00. On average, they anticipate the company's stock price to reach $353.00 in the next year. This suggests a possible upside of 5.3% from the stock's current price.
View analysts price targets for WAT
or view top-rated stocks among Wall Street analysts.

How have WAT shares performed in 2022?

Waters' stock was trading at $372.60 at the beginning of 2022. Since then, WAT stock has decreased by 10.0% and is now trading at $335.23.
View the best growth stocks for 2022 here
.

Are investors shorting Waters?

Waters saw a increase in short interest during the month of July. As of July 31st, there was short interest totaling 1,240,000 shares, an increase of 19.2% from the July 15th total of 1,040,000 shares. Based on an average daily volume of 389,100 shares, the days-to-cover ratio is currently 3.2 days. Currently, 2.1% of the shares of the company are short sold.
View Waters' Short Interest
.

When is Waters' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 1st 2022.
View our WAT earnings forecast
.

How were Waters' earnings last quarter?

Waters Co. (NYSE:WAT) posted its quarterly earnings data on Tuesday, August, 2nd. The medical instruments supplier reported $2.75 earnings per share for the quarter, topping analysts' consensus estimates of $2.63 by $0.12. The medical instruments supplier had revenue of $714.30 million for the quarter, compared to analyst estimates of $706.77 million. Waters had a trailing twelve-month return on equity of 203.31% and a net margin of 24.21%. The company's revenue was up 4.8% compared to the same quarter last year. During the same period in the prior year, the company earned $2.60 EPS.
Read the conference call transcript
.

What guidance has Waters issued on next quarter's earnings?

Waters updated its third quarter 2022 earnings guidance on Tuesday, August, 9th. The company provided EPS guidance of $2.50-$2.60 for the period, compared to the consensus estimate of $2.70. The company issued revenue guidance of $672.42 million-$685.60 million, compared to the consensus revenue estimate of $683.37 million.

What is Udit Batra's approval rating as Waters' CEO?

13 employees have rated Waters Chief Executive Officer Udit Batra on Glassdoor.com. Udit Batra has an approval rating of 100% among the company's employees. This puts Udit Batra in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Waters own?

What is Waters' stock symbol?

Waters trades on the New York Stock Exchange (NYSE) under the ticker symbol "WAT."

Who are Waters' major shareholders?

Waters' stock is owned by a variety of institutional and retail investors. Top institutional investors include Massachusetts Financial Services Co. MA (4.10%), Northern Trust Corp (1.32%), FMR LLC (1.00%), Mawer Investment Management Ltd. (0.93%), Boston Trust Walden Corp (0.67%) and Sumitomo Mitsui Trust Holdings Inc. (0.57%). Insiders that own company stock include Christopher A Kuebler, Christopher J Oconnell, Edward Conard, Elizabeth B Rae, Francis Kim, Ian King, Joann A Reed, Keeley A Aleman, Laurie H MD Glimcher, Linda Baddour, Mark T Beaudouin, Michael C Harrington, Michael J Berendt, Robert G Carson, Sherry Buck and Thomas P Salice.
View institutional ownership trends
.

How do I buy shares of Waters?

Shares of WAT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Waters' stock price today?

One share of WAT stock can currently be purchased for approximately $335.23.

How much money does Waters make?

Waters (NYSE:WAT) has a market capitalization of $20.07 billion and generates $2.79 billion in revenue each year. The medical instruments supplier earns $692.84 million in net income (profit) each year or $11.46 on an earnings per share basis.

How many employees does Waters have?

The company employs 7,800 workers across the globe.

Does Waters have any subsidiaries?

The following companies are subsidiares of Waters: Analytical Products Group Inc., Andrew Alliance, Andrew Alliance S.A, Andrew Alliance SA (Switzerland), Andrew Alliance SASU (France), Anter Corporation, Baehr Thermoanalyse GmbH, Blue Reference Inc., Calorimetry Sciences Corporation, ElectroForce, Environmental Resource Associates Inc. (Colorado), Environmental Resources Associates, Integrated Software Solutions, Integrated Software Solutions Limited (UK), Integrated Software Solutions USA LLC, MPE Orbur Group Ltd. (UK), Manchester International Limited (Cayman), Melbourne International Limited (Cayman), Micromass Holdings Ltd. (UK), Micromass Ltd. (UK), Micromass UK Ltd. (UK), Midland Precision Equipment Co. Ltd. (UK), Milford International Limited (Cayman), Nihon Waters K.K. (Japan), NuGenesis Technologies Corporation, Rubotherm, TA Instruments Japan Inc. (Japan), TA Instruments-Waters LLC (Delaware), Thar Instruments Inc, Thermometric AB, VICAM, VTI Corporation, Waters (TC) Israel Ltd. (Israel), Waters A/S (Denmark), Waters AG (Switzerland), Waters Analytical Instruments Sdn Bhd (Malaysia), Waters Asia Limited (Delaware), Waters Australia PTY LTD. (Australia), Waters Celtic Holdings Ltd. (Ireland), Waters China Ltd. (Hong Kong), Waters Chromatography BV (Netherlands), Waters Chromatography Europe BV (Netherlands), Waters Chromatography Ireland Ltd. (Ireland), Waters Corporation (Delaware), Waters Cromatografia SA (Spain), Waters European Investments LLC (Cayman) (2), Waters Ges.MBH (Austria), Waters Global International Limited (Cayman) (1), Waters Global Limited (UK) (1), Waters GmbH (Germany), Waters Holdings LLC (Delaware), Waters India Pvt. Ltd., Waters Kft (Hungary), Waters Korea Limited (Korea), Waters Limited (Canada), Waters Limited (UK), Waters Luxembourg SARL (Luxembourg), Waters NV (Belgium), Waters O.O.O. (Russia) (1), Waters Pacific Pte Ltd. (Singapore), Waters Research Center Kft (Hungary), Waters Romania Srl, Waters SA de CV (Mexico), Waters SAS (France), Waters Sp.Zo.o (Poland), Waters SpA (Italy), Waters Sverige AB (Sweden), Waters Tech. LC-MS Unipessol Lda (Portugal), Waters Technologies (Beijing) Co. Ltd (China), Waters Technologies (Shanghai) Ltd (China), Waters Technologies Corporation (Delaware), Waters Technologies International Limited (Cayman) (1), Waters Technologies Ireland Ltd. (Ireland), and Waters Technologies do Brasil Ltda (Brazil).
Read More

When was Waters founded?

Waters was founded in 1958.

How can I contact Waters?

Waters' mailing address is 34 MAPLE STREET, MILFORD MA, 01757. The official website for the company is www.waters.com. The medical instruments supplier can be reached via phone at (508) 478-2000, via email at investor_relations@waters.com, or via fax at 508-872-1990.

This page (NYSE:WAT) was last updated on 8/14/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.